BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McNamara A L, Willers H, Paganetti H. Modelling variable proton relative biological effectiveness for treatment planning. Br J Radiol 2020;93:20190334. [PMID: 31738081 DOI: 10.1259/bjr.20190334] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Borbinha J, Ferreira P, Costa D, Vaz P, Di Maria S. Targeted radionuclide therapy directed to the tumor phenotypes: A dosimetric approach using MC simulations. Applied Radiation and Isotopes 2022. [DOI: 10.1016/j.apradiso.2022.110569] [Reference Citation Analysis]
2 Tian L, Hahn C, Lühr A. An ion-independent phenomenological relative biological effectiveness (RBE) model for proton therapy. Radiother Oncol 2022;174:69-76. [PMID: 35803365 DOI: 10.1016/j.radonc.2022.06.023] [Reference Citation Analysis]
3 Jones B. Risk assessment for proton therapy in the central nervous system by assuming small increments in RBE. Radiation Physics and Chemistry 2022. [DOI: 10.1016/j.radphyschem.2022.110213] [Reference Citation Analysis]
4 Liu C, Bradley JA, Zheng D, Vega RBM, Beltran CJ, Mendenhall N, Liang X. RBE‐weighted dose and its impact on the risk of acute coronary event for breast cancer patients treated with intensity modulated proton therapy. J Applied Clin Med Phys. [DOI: 10.1002/acm2.13527] [Reference Citation Analysis]
5 Rucinski A, Biernacka A, Schulte R. Applications of nanodosimetry in particle therapy planning and beyond. Phys Med Biol 2021;66. [PMID: 34731854 DOI: 10.1088/1361-6560/ac35f1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pietrzak M, Mietelska M, Bancer A, Rucinski A, Brzozowska B. Geant4-DNA modeling of nanodosimetric quantities in the Jet Counter for alpha particles. Phys Med Biol 2021;66. [PMID: 34706345 DOI: 10.1088/1361-6560/ac33eb] [Reference Citation Analysis]
7 van de Kamp G, Heemskerk T, Kanaar R, Essers J. DNA Double Strand Break Repair Pathways in Response to Different Types of Ionizing Radiation. Front Genet 2021;12:738230. [PMID: 34659358 DOI: 10.3389/fgene.2021.738230] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
8 Gordon KB, Smyk DI, Gulidov IA. Proton Therapy in Head and Neck Cancer Treatment: State of the Problem and Development Prospects (Review). Sovrem Tekhnologii Med 2021;13:70-80. [PMID: 34603766 DOI: 10.17691/stm2021.13.4.08] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bellinzona EV, Grzanka L, Attili A, Tommasino F, Friedrich T, Krämer M, Scholz M, Battistoni G, Embriaco A, Chiappara D, Cirrone GAP, Petringa G, Durante M, Scifoni E. Biological Impact of Target Fragments on Proton Treatment Plans: An Analysis Based on the Current Cross-Section Data and a Full Mixed Field Approach. Cancers (Basel) 2021;13:4768. [PMID: 34638254 DOI: 10.3390/cancers13194768] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Suckert T, Nexhipi S, Dietrich A, Koch R, Kunz-Schughart LA, Bahn E, Beyreuther E. Models for Translational Proton Radiobiology-From Bench to Bedside and Back. Cancers (Basel) 2021;13:4216. [PMID: 34439370 DOI: 10.3390/cancers13164216] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
11 A. Taylor P. Clinical Trials Evaluating Proton Therapy. Proton Therapy - Current Status and Future Directions 2021. [DOI: 10.5772/intechopen.95957] [Reference Citation Analysis]
12 Bláha P, Feoli C, Agosteo S, Calvaruso M, Cammarata FP, Catalano R, Ciocca M, Cirrone GAP, Conte V, Cuttone G, Facoetti A, Forte GI, Giuffrida L, Magro G, Margarone D, Minafra L, Petringa G, Pucci G, Ricciardi V, Rosa E, Russo G, Manti L. The Proton-Boron Reaction Increases the Radiobiological Effectiveness of Clinical Low- and High-Energy Proton Beams: Novel Experimental Evidence and Perspectives. Front Oncol 2021;11:682647. [PMID: 34262867 DOI: 10.3389/fonc.2021.682647] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
13 McMahon SJ. Proton RBE models: commonalities and differences. Phys Med Biol 2021;66:04NT02. [PMID: 33429381 DOI: 10.1088/1361-6560/abda98] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
14 Otterlei OM, Indelicato DJ, Toussaint L, Ytre-Hauge KS, Pilskog S, Fjaera LF, Rørvik E, Pettersen HES, Muren LP, Lassen-Ramshad Y, Di Pinto M, Stokkevåg CH. Variation in relative biological effectiveness for cognitive structures in proton therapy of pediatric brain tumors. Acta Oncol 2021;60:267-74. [PMID: 33131367 DOI: 10.1080/0284186X.2020.1840626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
15 Cozzi L, Comito T, Loi M, Fogliata A, Franzese C, Franceschini D, Clerici E, Reggiori G, Tomatis S, Scorsetti M. The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation. Technol Cancer Res Treat 2020;19:1533033820980412. [PMID: 33287650 DOI: 10.1177/1533033820980412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Wu J, Xie Y, Wang L, Wang Y. Monte Carlo simulations of energy deposition and DNA damage using TOPAS-nBio. Phys Med Biol 2020;65:225007. [DOI: 10.1088/1361-6560/abbb73] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Franceschini D, Cozzi L, Loi M, Franzese C, Reggiori G, Mancosu P, Clivio A, Fogliata A, Scorsetti M. Volumetric modulated arc therapy vs intensity-modulated proton therapy in the postoperative irradiation of thymoma. J Cancer Res Clin Oncol. 2020;146:2267-2276. [PMID: 32514629 DOI: 10.1007/s00432-020-03281-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Celik E, Baus W, Baues C, Schröder W, Clivio A, Fogliata A, Scorsetti M, Marnitz S, Cozzi L. Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer. Radiat Oncol 2020;15:120. [PMID: 32448296 DOI: 10.1186/s13014-020-01570-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
19 McNamara AL, Hall DC, Shusharina N, Liu A, Wei X, Ajdari A, Mohan R, Liao Z, Paganetti H. Perspectives on the model-based approach to proton therapy trials: A retrospective study of a lung cancer randomized trial. Radiother Oncol 2020;147:8-14. [PMID: 32224318 DOI: 10.1016/j.radonc.2020.02.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
20 Held KD, Lomax AJ, Troost EGC. Proton therapy special feature: introductory editorial. Br J Radiol 2020;93:20209004. [PMID: 32081045 DOI: 10.1259/bjr.20209004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]